Horwitz SB - Search Results

1

Targeting protein translation in human non small cell lung cancer via combined MEK and mammalian target of rapamycin suppression.

Legrier ME, Yang CP, Yan HG, Lopez-Barcons L, Keller SM, Pérez-Soler R, Horwitz SB, McDaid HM. Legrier ME, et al. Among authors: horwitz sb. Cancer Res. 2007 Dec 1;67(23):11300-8. doi: 10.1158/0008-5472.CAN-07-0702. Cancer Res. 2007. PMID: 18056456

2

Gene expression and mitotic exit induced by microtubule-stabilizing drugs.

Chen JG, Yang CP, Cammer M, Horwitz SB. Chen JG, et al. Among authors: horwitz sb. Cancer Res. 2003 Nov 15;63(22):7891-9. Cancer Res. 2003. PMID: 14633718

3

Enhancement of the therapeutic efficacy of taxol by the mitogen-activated protein kinase kinase inhibitor CI-1040 in nude mice bearing human heterotransplants.

McDaid HM, Lopez-Barcons L, Grossman A, Lia M, Keller S, Pérez-Soler R, Horwitz SB. McDaid HM, et al. Among authors: horwitz sb. Cancer Res. 2005 Apr 1;65(7):2854-60. doi: 10.1158/0008-5472.CAN-04-4391. Cancer Res. 2005. PMID: 15805287

4

Potentiation of taxol efficacy and by discodermolide in ovarian carcinoma xenograft-bearing mice.

Huang GS, Lopez-Barcons L, Freeze BS, Smith AB 3rd, Goldberg GL, Horwitz SB, McDaid HM. Huang GS, et al. Among authors: horwitz sb. Clin Cancer Res. 2006 Jan 1;12(1):298-304. doi: 10.1158/1078-0432.CCR-05-0229. Clin Cancer Res. 2006. PMID: 16397055 Free PMC article.

5

Distinct mechanisms of taxol-induced serine phosphorylation of the 66-kDa Shc isoform in A549 and RAW 264.7 cells.

Yang CP, Horwitz SB. Yang CP, et al. Among authors: horwitz sb. Biochim Biophys Acta. 2002 Jun 12;1590(1-3):76-83. doi: 10.1016/s0167-4889(02)00200-8. Biochim Biophys Acta. 2002. PMID: 12063170 Free article.

6

Taxol mediates serine phosphorylation of the 66-kDa Shc isoform.

Yang CP, Horwitz SB. Yang CP, et al. Among authors: horwitz sb. Cancer Res. 2000 Sep 15;60(18):5171-8. Cancer Res. 2000. PMID: 11016645

7

Selective potentiation of paclitaxel (taxol)-induced cell death by mitogen-activated protein kinase kinase inhibition in human cancer cell lines.

McDaid HM, Horwitz SB. McDaid HM, et al. Among authors: horwitz sb. Mol Pharmacol. 2001 Aug;60(2):290-301. doi: 10.1124/mol.60.2.290. Mol Pharmacol. 2001. PMID: 11455016 Free PMC article.

8

The effect of ketoconazole on the pharmacokinetics and pharmacodynamics of ixabepilone: a first in class epothilone B analogue in late-phase clinical development.

Goel S, Cohen M, Cömezoglu SN, Perrin L, André F, Jayabalan D, Iacono L, Comprelli A, Ly VT, Zhang D, Xu C, Humphreys WG, McDaid H, Goldberg G, Horwitz SB, Mani S. Goel S, et al. Among authors: horwitz sb. Clin Cancer Res. 2008 May 1;14(9):2701-9. doi: 10.1158/1078-0432.CCR-07-4151. Clin Cancer Res. 2008. PMID: 18451235 Clinical Trial.

9

Wild-type class I beta-tubulin sensitizes Taxol-resistant breast adenocarcinoma cells harboring a beta-tubulin mutation.

Wiesen KM, Xia S, Yang CP, Horwitz SB. Wiesen KM, et al. Among authors: horwitz sb. Cancer Lett. 2007 Nov 18;257(2):227-35. doi: 10.1016/j.canlet.2007.07.022. Epub 2007 Sep 14. Cancer Lett. 2007. PMID: 17869412

10

The interaction between mitotic checkpoint proteins, CENP-E and BubR1, is diminished in epothilone B-resistant A549 cells.

Yang CP, Liu L, Ikui AE, Horwitz SB. Yang CP, et al. Among authors: horwitz sb. Cell Cycle. 2010 Mar 15;9(6):1207-13. doi: 10.4161/cc.9.6.11122. Epub 2010 Mar 15. Cell Cycle. 2010. PMID: 20237434

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

224 results

Search Page

Filters